Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 10 | 2019 | 185 | 1.850 |
Why?
|
| Burns | 10 | 2018 | 102 | 1.380 |
Why?
|
| Wounds and Injuries | 6 | 2019 | 242 | 1.050 |
Why?
|
| Collagen | 4 | 2020 | 229 | 0.700 |
Why?
|
| Vitamin A Deficiency | 1 | 2019 | 4 | 0.620 |
Why?
|
| Vitamin A | 1 | 2019 | 21 | 0.620 |
Why?
|
| Vitamins | 1 | 2019 | 71 | 0.600 |
Why?
|
| Nutritional Support | 1 | 2016 | 5 | 0.500 |
Why?
|
| Diabetic Foot | 2 | 2016 | 23 | 0.500 |
Why?
|
| Pressure Ulcer | 1 | 2016 | 8 | 0.500 |
Why?
|
| Malnutrition | 1 | 2016 | 21 | 0.490 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2016 | 1 | 0.480 |
Why?
|
| Explosive Agents | 1 | 2016 | 1 | 0.480 |
Why?
|
| Eye Foreign Bodies | 1 | 2016 | 2 | 0.480 |
Why?
|
| Finger Phalanges | 1 | 2016 | 7 | 0.480 |
Why?
|
| Multiple Trauma | 1 | 2016 | 41 | 0.470 |
Why?
|
| Blast Injuries | 1 | 2016 | 30 | 0.460 |
Why?
|
| Fractures, Bone | 1 | 2016 | 142 | 0.420 |
Why?
|
| Wound Infection | 3 | 2018 | 12 | 0.410 |
Why?
|
| Skin Transplantation | 4 | 2018 | 50 | 0.410 |
Why?
|
| Siloxanes | 1 | 2013 | 2 | 0.400 |
Why?
|
| Papilloma | 1 | 2013 | 8 | 0.400 |
Why?
|
| Morpholines | 1 | 2013 | 47 | 0.390 |
Why?
|
| Piperazines | 1 | 2013 | 60 | 0.380 |
Why?
|
| Dietary Supplements | 2 | 2019 | 188 | 0.380 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 220 | 0.370 |
Why?
|
| Reconstructive Surgical Procedures | 3 | 2011 | 191 | 0.350 |
Why?
|
| Suction | 3 | 2006 | 10 | 0.350 |
Why?
|
| Chondroitin Sulfates | 2 | 2009 | 23 | 0.340 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 1083 | 0.340 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2011 | 38 | 0.340 |
Why?
|
| Soft Tissue Injuries | 2 | 2009 | 18 | 0.340 |
Why?
|
| Humans | 29 | 2020 | 32274 | 0.330 |
Why?
|
| Biocompatible Materials | 2 | 2019 | 240 | 0.310 |
Why?
|
| Skin, Artificial | 4 | 2019 | 34 | 0.310 |
Why?
|
| Skin | 3 | 2020 | 212 | 0.310 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2009 | 26 | 0.290 |
Why?
|
| Adult | 16 | 2018 | 9256 | 0.280 |
Why?
|
| Tryptophan | 1 | 2008 | 7 | 0.270 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2008 | 4 | 0.270 |
Why?
|
| Food, Fortified | 1 | 2008 | 4 | 0.270 |
Why?
|
| Nutritional Requirements | 1 | 2008 | 15 | 0.270 |
Why?
|
| Electric Injuries | 1 | 2007 | 12 | 0.270 |
Why?
|
| Nerve Transfer | 1 | 2007 | 19 | 0.260 |
Why?
|
| Dietary Proteins | 1 | 2008 | 63 | 0.260 |
Why?
|
| Achilles Tendon | 1 | 2007 | 26 | 0.260 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 762 | 0.250 |
Why?
|
| Vacuum | 6 | 2008 | 23 | 0.250 |
Why?
|
| Surgical Wound Infection | 2 | 2011 | 99 | 0.240 |
Why?
|
| Surgical Flaps | 2 | 2007 | 76 | 0.240 |
Why?
|
| Animals | 8 | 2020 | 8199 | 0.210 |
Why?
|
| Facial Injuries | 2 | 2016 | 11 | 0.210 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 312 | 0.210 |
Why?
|
| Lichen Planus | 1 | 2004 | 10 | 0.210 |
Why?
|
| Acitretin | 1 | 2004 | 18 | 0.210 |
Why?
|
| Keratolytic Agents | 1 | 2004 | 29 | 0.210 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2015 | 56 | 0.190 |
Why?
|
| Male | 16 | 2020 | 19437 | 0.190 |
Why?
|
| Atmospheric Pressure | 3 | 2009 | 11 | 0.190 |
Why?
|
| Burn Units | 1 | 2002 | 28 | 0.180 |
Why?
|
| Pleural Diseases | 1 | 2002 | 1 | 0.180 |
Why?
|
| Respiratory Tract Fistula | 1 | 2002 | 2 | 0.180 |
Why?
|
| Bronchial Fistula | 1 | 2002 | 2 | 0.180 |
Why?
|
| Cutaneous Fistula | 1 | 2002 | 3 | 0.180 |
Why?
|
| Pneumonectomy | 1 | 2002 | 12 | 0.180 |
Why?
|
| Intensive Care Units | 1 | 2002 | 121 | 0.170 |
Why?
|
| Child | 5 | 2018 | 2434 | 0.150 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 79 | 0.150 |
Why?
|
| Middle Aged | 11 | 2018 | 11848 | 0.150 |
Why?
|
| Administration, Topical | 1 | 2019 | 142 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2019 | 200 | 0.150 |
Why?
|
| Water Microbiology | 1 | 2018 | 5 | 0.150 |
Why?
|
| Hydrotherapy | 1 | 2018 | 4 | 0.150 |
Why?
|
| Klebsiella Infections | 1 | 2018 | 6 | 0.150 |
Why?
|
| Equipment Contamination | 1 | 2018 | 13 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 35 | 0.140 |
Why?
|
| Cross Infection | 1 | 2018 | 57 | 0.140 |
Why?
|
| Edema | 2 | 2011 | 29 | 0.130 |
Why?
|
| Female | 12 | 2018 | 19942 | 0.130 |
Why?
|
| Bandages | 3 | 2009 | 34 | 0.130 |
Why?
|
| Fibroblasts | 2 | 2020 | 119 | 0.130 |
Why?
|
| Varicose Ulcer | 1 | 2016 | 4 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2016 | 413 | 0.120 |
Why?
|
| Tissue Engineering | 2 | 2020 | 695 | 0.120 |
Why?
|
| Occlusive Dressings | 2 | 2008 | 10 | 0.120 |
Why?
|
| Lacerations | 1 | 2016 | 9 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 51 | 0.120 |
Why?
|
| Burns, Chemical | 1 | 2016 | 7 | 0.120 |
Why?
|
| Explosions | 1 | 2016 | 18 | 0.120 |
Why?
|
| Compartment Syndromes | 2 | 2009 | 36 | 0.120 |
Why?
|
| Eye Injuries | 1 | 2016 | 15 | 0.120 |
Why?
|
| Surgery, Plastic | 1 | 2016 | 29 | 0.120 |
Why?
|
| Hand Injuries | 1 | 2016 | 24 | 0.120 |
Why?
|
| Arm Injuries | 1 | 2016 | 20 | 0.120 |
Why?
|
| Pressure | 3 | 2004 | 69 | 0.120 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 52 | 0.120 |
Why?
|
| Ulnar Neuropathies | 1 | 2015 | 17 | 0.110 |
Why?
|
| Neuromuscular Junction | 1 | 2015 | 70 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3416 | 0.110 |
Why?
|
| Adolescent | 5 | 2018 | 3517 | 0.110 |
Why?
|
| Mice | 3 | 2020 | 2571 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2018 | 40 | 0.100 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2013 | 5 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 11 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2013 | 17 | 0.100 |
Why?
|
| Antigens, Viral | 1 | 2013 | 21 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1179 | 0.100 |
Why?
|
| Carcinogens | 1 | 2013 | 36 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2018 | 1233 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2016 | 330 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2013 | 78 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2013 | 66 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2018 | 2316 | 0.090 |
Why?
|
| Facial Transplantation | 1 | 2011 | 8 | 0.090 |
Why?
|
| Lung | 1 | 2013 | 263 | 0.090 |
Why?
|
| Steroids | 1 | 2011 | 35 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2013 | 839 | 0.080 |
Why?
|
| Median Nerve | 1 | 2011 | 50 | 0.080 |
Why?
|
| Abdominal Wall | 2 | 2008 | 24 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 85 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2009 | 3624 | 0.080 |
Why?
|
| Public Policy | 1 | 2009 | 31 | 0.080 |
Why?
|
| Keloid | 1 | 2009 | 8 | 0.070 |
Why?
|
| Public Health | 1 | 2009 | 91 | 0.070 |
Why?
|
| Diclofenac | 1 | 2007 | 3 | 0.070 |
Why?
|
| External Fixators | 1 | 2007 | 18 | 0.070 |
Why?
|
| Amino Acids | 1 | 2008 | 52 | 0.070 |
Why?
|
| Debridement | 1 | 2007 | 45 | 0.070 |
Why?
|
| Sural Nerve | 1 | 2007 | 25 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2007 | 45 | 0.060 |
Why?
|
| Acute Disease | 2 | 2006 | 253 | 0.060 |
Why?
|
| Aged | 5 | 2018 | 10260 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 66 | 0.060 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2006 | 11 | 0.060 |
Why?
|
| Science | 1 | 2006 | 8 | 0.060 |
Why?
|
| Equipment Design | 1 | 2006 | 178 | 0.060 |
Why?
|
| Smoke Inhalation Injury | 1 | 2005 | 6 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 28 | 0.050 |
Why?
|
| Frostbite | 1 | 2004 | 1 | 0.050 |
Why?
|
| Nevus | 1 | 2004 | 17 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2004 | 13 | 0.050 |
Why?
|
| Triamcinolone | 1 | 2004 | 12 | 0.050 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 55 | 0.050 |
Why?
|
| Scalp | 1 | 2004 | 35 | 0.050 |
Why?
|
| Clobetasol | 1 | 2004 | 26 | 0.050 |
Why?
|
| Mandibular Fractures | 1 | 2003 | 7 | 0.050 |
Why?
|
| Swine | 1 | 2004 | 228 | 0.050 |
Why?
|
| Fracture Fixation | 1 | 2003 | 42 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2003 | 106 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 292 | 0.050 |
Why?
|
| Surgical Mesh | 2 | 2018 | 50 | 0.050 |
Why?
|
| Rhabdomyolysis | 1 | 2002 | 6 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2004 | 146 | 0.050 |
Why?
|
| Myoglobin | 1 | 2002 | 11 | 0.050 |
Why?
|
| Patient Isolation | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2016 | 553 | 0.050 |
Why?
|
| Empyema, Pleural | 1 | 2002 | 7 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2002 | 14 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2648 | 0.040 |
Why?
|
| Mortality | 1 | 2002 | 122 | 0.040 |
Why?
|
| Infant | 2 | 2018 | 1010 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2015 | 393 | 0.040 |
Why?
|
| Hospitalization | 1 | 2003 | 475 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 30 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 102 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 285 | 0.040 |
Why?
|
| Zambia | 1 | 2018 | 1 | 0.040 |
Why?
|
| Disinfection | 1 | 2018 | 6 | 0.040 |
Why?
|
| Incidence | 1 | 2002 | 1241 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 28 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2018 | 27 | 0.040 |
Why?
|
| beta-Lactamases | 1 | 2018 | 13 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 100 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 520 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3898 | 0.030 |
Why?
|
| Extremities | 2 | 2009 | 54 | 0.030 |
Why?
|
| Regeneration | 1 | 2019 | 178 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 955 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 431 | 0.030 |
Why?
|
| Electrodiagnosis | 1 | 2015 | 41 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2016 | 113 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 27 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 158 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2011 | 82 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2011 | 236 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2009 | 8 | 0.020 |
Why?
|
| Streptomycin | 1 | 2007 | 2 | 0.020 |
Why?
|
| Salmonella enterica | 1 | 2007 | 6 | 0.020 |
Why?
|
| Trifluoperazine | 1 | 2007 | 4 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 18 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 28 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 50 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 66 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 48 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 78 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2007 | 30 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2007 | 88 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2007 | 39 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 2240 | 0.020 |
Why?
|
| Mediastinitis | 1 | 2006 | 7 | 0.020 |
Why?
|
| Intestinal Fistula | 1 | 2006 | 9 | 0.020 |
Why?
|
| Perineum | 1 | 2006 | 17 | 0.020 |
Why?
|
| Sternum | 1 | 2006 | 13 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 324 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 93 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2005 | 56 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 60 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 1425 | 0.010 |
Why?
|
| Hindlimb | 1 | 2002 | 53 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 219 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 444 | 0.010 |
Why?
|